EUVIMEDEUVIMED entdecken
QuerschnittstudieOpen Access · CC BY 4.0

Analysis of gut microbiota in patients with AVS and identification of potential biomarkers: a cross-sectional study

Fei Jiang, Meiling Cai, Yanchun Peng, Sailan Li, Yuling Xie, Qiong Pan, Jianlong Lin, Bing Liang, Liangwan Chen iD, Yanjuan Lin iD

Microbiology Spectrum · 2025

DOI: 10.1128/spectrum.03215-24 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift Microbiology Spectrum, 2025. Verfasst von Fei Jiang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nursing, Fujian Medical University Union Hospital, Fuzhou, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Bacteria, Aortic Valve Stenosis. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Fujian Provincial Department of Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study evaluated the characteristics of the gut microbial (GM) in patients with aortic valve stenosis (AVS). Thirty patients diagnosed with AVS and 30 healthy controls (HC) were included. Fecal samples were obtained for high-throughput 16S rDNA sequencing. Bacterial diversity was assessed using QIIME and R software. Potential biomarkers were identified using the random forest model. The model performance was evaluated using receiver operating characteristic (ROC) curves and decision curve analysis. Relationships between the GM and clinical characteristics of participants were examined using the Spearman’s correlation. The composition of GM, measured by beta diversity, significantly differed between the two groups (Adonis, P = 0.001), indicating distinct microbial community structures in AVS patients compared to HC. At the phylum level, the Firmicutes / Bacteroidetes (F/B) ratio was significantly lower in the AVS group compared to the HC group ( P = 0.031, Wilcoxon test). At the genus level, the relative abundance of short-chain fatty acids (SCFAs)-producing bacteria, including Lachnospiraceae , Prevotellaceae , and Enterococcus, was significantly reduced. Twenty-four genera were identified as potential biomarkers using the nested cross-validation feature of the random forest model (86.67% accuracy in cross-validation). The area under the receiver operating characteristic curve (AUC) was 0.94 (95% CI = 0.79–1.00). The decision curve analysis highlighted the practical utility of the model in clinical settings. Patients with AVS exhibited alterations in GM, particularly a reduction in the SCFAs-producing bacteria. The distinct GM profiles demonstrated strong predictive capabilities for AVS and were related to the worsening of clinical indicators. Notably, 24 genera may serve as potential biomarkers and predictors in clinical settings. IMPORTANCE Dysbiosis of GM contributes to cardiovascular diseases; however, research on GM alterations in patients with aortic valve stenosis (AVS) is limited. The study aimed to conduct a cross-sectional study matched for age, sex, body mass index (BMI), and patient geographic region, to analyze the GM in patients with AVS, to identify potential biomarkers, and to assess the effectiveness of clinical prediction. If this correlation is confirmed, the GM may be used for risk stratification and identification of potential therapeutic targets. CLINICAL TRIALS This clinical study was registered with the China Clinical Trials Registration Center (No. ChiCTR2400081198 ).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeBacteriaAortic Valve StenosisHumansMaleFemaleCross-Sectional StudiesBiomarkersAgedFecesMiddle AgedRNA, Ribosomal, 16SFatty Acids, VolatileROC Curve

Stichwörter der Autor:innen

aortic valve stenosisgut microbiotarandom forestshort-chain fatty acids

Substanzen

BiomarkersRNA, Ribosomal, 16SFatty Acids, Volatile

Autor:innen und Institutionen

  • Department of Nursing, Fujian Medical University Union Hospital, Fuzhou, China.
  • Department of Cardiovascular Surgery, Fujian Medical University Union Hospital, Fuzhou, China.
  • Key Laboratory of Cardio-Thoracic Surgery (Fujian Medical University), Fujian Province University, Fuzhou, China.
  • Department of Physical Examination, Fujian Medical University Union Hospital, Fuzhou, China.

ORCID-Profile: Liangwan Chen, Yanjuan Lin

Förderung

  • National Natural Science Foundation of China
  • Fujian Provincial Department of Science and Technology

Zitieren

APA

Jiang, F., Cai, M., Peng, Y., Li, S., Xie, Y., Pan, Q., Lin, J., Liang, B., Chen, L., & Lin, Y. (2025). Analysis of gut microbiota in patients with AVS and identification of potential biomarkers: a cross-sectional study. Microbiology Spectrum. https://doi.org/10.1128/spectrum.03215-24

Vancouver

Jiang F, Cai M, Peng Y, Li S, Xie Y, Pan Q, et al. Analysis of gut microbiota in patients with AVS and identification of potential biomarkers: a cross-sectional study. Microbiology Spectrum. 2025. doi:10.1128/spectrum.03215-24

BibTeX
@article{Jiang2025,
  author = {Jiang, Fei and Cai, Meiling and Peng, Yanchun and Li, Sailan and Xie, Yuling and Pan, Qiong and Lin, Jianlong and Liang, Bing and Chen, Liangwan and Lin, Yanjuan},
  title = {Analysis of gut microbiota in patients with AVS and identification of potential biomarkers: a cross-sectional study},
  journal = {Microbiology Spectrum},
  year = {2025},
  doi = {10.1128/spectrum.03215-24}
}
Kostenlos starten →